✦ LIBER ✦

Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia

✍ Scribed by Deepika Bhatla; Robert B. Gerbing; Todd A. Alonzo; Heather Conner; Julie A. Ross; Soheil Meshinchi; Xiaowen Zhai; Tiffany Zamzow; Parinda A. Mehta; Hartmut Geiger; John Perentesis; Stella M. Davies

Book ID: 108676070
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 102 KB
Volume: 144
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2008.07461.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cytosine arabinoside and dauno

High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia

✍ G. Heil; P. S. Mitrou; D. Hoelzer; M. Freund; H. Link; G. Ehninger; B. Steinke; 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 746 KB

Therapy of refractory/relapsed acute mye

Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin

✍ Jonathan H. Marsh; Willi Kreis; Barbara Barile; Silvia Akerman; Philip Schulman; 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 428 KB

Short courses of cytosine arabinoside an

Short courses of cytosine arabinoside and L-asparaginase in children with acute leukemia

✍ H. Ekert; J. H. Colebatch; R. N. Matthews 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

Courses of cytosine arabinoside followed by L-asparaginase were administered for 4 days each to 17 children with previously treated acute lymphatic leukemia, at 14to 27-day intervals. Complete or partial remission occurred in 81% of patients after the third or fourth course of therapy. Rlaintenance

Results of conventional-dose cytosine ar

Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia

✍ A. Heyll; C. Aul; F. Gogolin; V. Runde; D. Söhngen; G. Meckenstock; H. -H. Wolf; 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 549 KB

Treatment of refractory acute myeloid le

Treatment of refractory acute myeloid leukemia with high-dose cytosine arabinoside and mitoxantrone in combination

✍ W. Hiddemann; H. Kreutzmann; W.D. Ludwig; H.C. Aul; R. Donhuijsen-Ant; E. Lengfe 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 92 KB

P-glycoprotein in primary acute myeloid

P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy

✍ Broxterman, H J; Sonneveld, P; van Putten, W J L; Lankelma, J; Eekman, C A; Osse 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 131 KB